Consultant Haematologist
The Institute of Cancer Research; Royal Marsden Hospital
Sutton, England, United Kingdom
Dr Martin Kaiser is a Reader in Molecular Haematology at the Institute of Cancer Research (ICR) and Haematology Consultant at the Royal Marsden Hospital in London, with special interest in plasma cell dyscrasias/multiple myeloma. His research focuses on molecular and imaging biomarkers in myeloma, with a view to personalisation of care and improving treatment value propositions for patients with multiple myeloma. He is vice chair of the UK NCRI myeloma trials subgroup and is actively involved in policy and advocacy work aiming to improve patient access to diagnostics and therapy.
Defining high risk and ultra-high risk MM
Saturday, September 30, 2023
11:15 AM – 11:25 AM EEST